首页 > 最新文献

Frontiers in pain research (Lausanne, Switzerland)最新文献

英文 中文
The effect of EMS, IFC, and TENS on patient-reported outcome measures for chronic low back pain: a systematic review and meta-analysis. EMS、IFC 和 TENS 对慢性腰背痛患者报告结果指标的影响:系统回顾和荟萃分析。
IF 2.5 Q2 CLINICAL NEUROLOGY Pub Date : 2024-06-24 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1346694
Daniel Wolfe, Brent Rosenstein, Maryse Fortin

Introduction: Chronic low back pain (CLBP) is the leading cause of years lived with disability worldwide. Transcutaneous electrotherapies have been widely used to treat CLBP but, with the partial exception of transcutaneous electrical nerve stimulation (TENS), their effect on pain, disability, quality-of-life, and psychosocial outcomes have not been systematically reviewed. The purpose of this systematic review and meta-analysis was to clarify the overall effect of transcutaneous electrotherapies on patient-reported outcome measures (PROMs) in CLBP patients.

Methods: Four databases and two study registries were searched for studies that utilized transcutaneous electrotherapies as a primary intervention for CLBP, compared against active or passive controls. Two reviewers independently extracted study data and assessed risk of bias. Studies were grouped by intervention vs. comparison, and by time of follow-up. Meta-analyses were conducted where appropriate.

Results: A total of 89 full-text were assessed for eligibility; 14 studies were included, with 6 in the meta-analyses (all TENS or mixed TENS). Pain: meta-analyses revealed no significant difference for TENS vs. active control, TENS vs. passive control, or mixed TENS vs. active control at post-intervention, nor for mixed TENS vs. active control at 1-month post-intervention. Interferential current (IFC) was more effective than active control (2 studies), while electromyostimulation (EMS) was generally superior to passive, but not active, controls (6 studies).

Disability: Meta-analyses revealed no significant difference for TENS vs. active control at post-intervention, mixed TENS vs. active control at post-intervention, or mixed TENS vs. active control at 1-month post-intervention. IFC was more effective than active control (2 studies), while the EMS results were mixed (6 studies). We were unable to perform meta-analyses for quality-of-life or psychosocial outcomes.

Conclusion: There is moderate evidence that TENS is similar to all controls for improving pain and disability. There is limited evidence that IFC is superior to active controls for improving pain and disability. There is limited evidence that EMS is superior to passive but not active controls for improving pain, and similar to all controls for improving disability.

Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=452851, Identifier (CRD42023452851).

导言:慢性腰背痛(CLBP)是导致全球残疾生活年限的主要原因。经皮电疗法已被广泛用于治疗慢性腰背痛,但除经皮神经电刺激(TENS)外,其他疗法对疼痛、残疾、生活质量和社会心理结果的影响尚未进行系统回顾。本系统综述和荟萃分析的目的是阐明经皮电疗法对慢性阻塞性脑脊髓膜炎患者的患者报告结果指标(PROMs)的总体影响:方法: 我们检索了四个数据库和两个研究登记处,以寻找将经皮电疗法作为CLBP主要干预措施的研究,并与主动或被动对照组进行比较。两名审稿人独立提取研究数据并评估偏倚风险。研究按照干预与对比以及随访时间进行分组。适当时进行元分析:共对 89 篇全文进行了资格评估;纳入了 14 项研究,其中 6 项纳入了荟萃分析(全部为 TENS 或混合 TENS)。疼痛:荟萃分析表明,在干预后,TENS 与主动对照组、TENS 与被动对照组、混合 TENS 与主动对照组没有显著差异,在干预后 1 个月,混合 TENS 与主动对照组也没有显著差异。干扰电流(IFC)比主动控制更有效(2 项研究),而肌电刺激(EMS)一般优于被动控制,但不优于主动控制(6 项研究):元分析显示,在干预后,TENS 与主动控制相比没有显著差异;在干预后,混合 TENS 与主动控制相比没有显著差异;在干预后 1 个月,混合 TENS 与主动控制相比也没有显著差异。IFC 比主动控制更有效(2 项研究),而 EMS 结果不一(6 项研究)。我们无法对生活质量或社会心理结果进行荟萃分析:结论:有中等程度的证据表明,TENS 在改善疼痛和残疾方面的效果与所有对照组相似。有限的证据表明,IFC 在改善疼痛和残疾方面优于积极的对照组。有限的证据表明,EMS 在改善疼痛方面优于被动对照组,但不优于主动对照组,在改善残疾方面与所有对照组相似。系统综述注册:https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=452851,标识符 (CRD42023452851)。
{"title":"The effect of EMS, IFC, and TENS on patient-reported outcome measures for chronic low back pain: a systematic review and meta-analysis.","authors":"Daniel Wolfe, Brent Rosenstein, Maryse Fortin","doi":"10.3389/fpain.2024.1346694","DOIUrl":"10.3389/fpain.2024.1346694","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic low back pain (CLBP) is the leading cause of years lived with disability worldwide. Transcutaneous electrotherapies have been widely used to treat CLBP but, with the partial exception of transcutaneous electrical nerve stimulation (TENS), their effect on pain, disability, quality-of-life, and psychosocial outcomes have not been systematically reviewed. The purpose of this systematic review and meta-analysis was to clarify the overall effect of transcutaneous electrotherapies on patient-reported outcome measures (PROMs) in CLBP patients.</p><p><strong>Methods: </strong>Four databases and two study registries were searched for studies that utilized transcutaneous electrotherapies as a primary intervention for CLBP, compared against active or passive controls. Two reviewers independently extracted study data and assessed risk of bias. Studies were grouped by intervention vs. comparison, and by time of follow-up. Meta-analyses were conducted where appropriate.</p><p><strong>Results: </strong>A total of 89 full-text were assessed for eligibility; 14 studies were included, with 6 in the meta-analyses (all TENS or mixed TENS). Pain: meta-analyses revealed no significant difference for TENS vs. active control, TENS vs. passive control, or mixed TENS vs. active control at post-intervention, nor for mixed TENS vs. active control at 1-month post-intervention. Interferential current (IFC) was more effective than active control (2 studies), while electromyostimulation (EMS) was generally superior to passive, but not active, controls (6 studies).</p><p><strong>Disability: </strong>Meta-analyses revealed no significant difference for TENS vs. active control at post-intervention, mixed TENS vs. active control at post-intervention, or mixed TENS vs. active control at 1-month post-intervention. IFC was more effective than active control (2 studies), while the EMS results were mixed (6 studies). We were unable to perform meta-analyses for quality-of-life or psychosocial outcomes.</p><p><strong>Conclusion: </strong>There is <i>moderate</i> evidence that TENS is similar to all controls for improving pain and disability. There is <i>limited</i> evidence that IFC is superior to active controls for improving pain and disability. There is <i>limited</i> evidence that EMS is superior to passive but not active controls for improving pain, and similar to all controls for improving disability.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=452851, Identifier (CRD42023452851).</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1346694"},"PeriodicalIF":2.5,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11228365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141560469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Insight in pediatric pain - 2023. 社论:洞察儿科疼痛--2023。
IF 2.5 Q2 CLINICAL NEUROLOGY Pub Date : 2024-06-21 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1437873
Anthony Herbert, Michael P Jankowski
{"title":"Editorial: Insight in pediatric pain - 2023.","authors":"Anthony Herbert, Michael P Jankowski","doi":"10.3389/fpain.2024.1437873","DOIUrl":"10.3389/fpain.2024.1437873","url":null,"abstract":"","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1437873"},"PeriodicalIF":2.5,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141556054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma concentrations of buprenorphine administered via matrix-type transdermal patches applied at three different anatomical locations in healthy adult horses. 在健康成年马的三个不同解剖位置通过基质型透皮贴片给药丁丙诺啡的血浆浓度。
IF 2.5 Q2 CLINICAL NEUROLOGY Pub Date : 2024-06-19 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1390322
Vaidehi V Paranjape, Heather K Knych, Londa J Berghaus, Shyla Giancola, Jessica Cathcart, Rachel A Reed

Background: Anatomical location-dependent differences in transdermal opioid penetration are well described in human patients. Although this has been investigated in horses with fentanyl, there is no literature available on location-dependent plasma buprenorphine concentrations when administered as a transdermal matrix-type patch.

Objective: This study aims to compare the plasma concentrations achieved from the matrix-type transdermal buprenorphine patches placed at different anatomical sites (metacarpus, gaskin, and ventral tail base) in healthy adult horses.

Study design: This is a randomized experimental study with a Latin square design.

Methods: Six adult horses were given each of three treatments with a minimum 10-day washout period. For each treatment, two 20 μg h-1 matrix-type buprenorphine patches were applied to the ventral aspect of the tail base (TailTDP), metacarpus region (MetacarpusTDP), or gaskin region (GaskinTDP). Whole blood samples (for determination of buprenorphine concentration) and physiological variables were collected before (0 h) and at 0.5, 2, 4, 6, 8, 10, 12, 16, 24, 32, 48, 56, 72, 96 and 120 h after patches were applied. The patches were removed 96 h following placement and were analyzed for residual buprenorphine content. Buprenorphine concentrations were measured in plasma by LC-MS/MS. A mixed-effects model was used to analyze the physiological variables.

Results: Between the three treatment groups, there was no change in physiological variables across timepoints as compared to baseline and when compared to each other in a single horse and between horses (p > 0.3). When comparing all three locations, the buprenorphine uptake was observed to be more consistent with respect to measurable plasma concentrations >0.1 ng ml-1 when applied to the ventral aspect of the tail base. In the TailTDP group, the mean plasma buprenorphine concentrations were >0.1 ng ml-1 from 2 to 32 h. The highest group mean was 0.25 ng ml-1 noted at 4 h.

Conclusions: The metacarpal and gaskin regions presented more erratic and inconsistent buprenorphine uptake and plasma concentrations as compared to the ventral aspect of the tail base. Further research must be directed at investigating the optimal dose, achievable duration of analgesia, change in measurable plasma concentrations, and behavioral and systemic effects.

背景:在人类患者中,透皮阿片类药物渗透性的解剖位置依赖性差异已得到充分描述。虽然在马匹身上用芬太尼进行过研究,但目前还没有文献报道以透皮基质型贴片形式给药时,丁丙诺啡的血浆浓度与位置有关:本研究旨在比较在健康成年马的不同解剖部位(掌骨、加斯金和腹侧尾根)贴上基质型透皮丁丙诺啡贴片后的血浆浓度:研究设计:这是一项采用拉丁方阵设计的随机实验研究:方法:六匹成年马分别接受三种治疗,每种治疗至少有 10 天的冲洗期。每种治疗均在马尾基部腹侧(TailTDP)、掌骨区(MetacarpusTDP)或胫骨区(GaskinTDP)贴上两片20微克/小时的基质型丁丙诺啡贴片。在贴片前(0 小时)和贴片后 0.5、2、4、6、8、10、12、16、24、32、48、56、72、96 和 120 小时收集全血样本(用于测定丁丙诺啡浓度)和生理变量。贴片贴上 96 小时后取下,分析残留的丁丙诺啡含量。通过 LC-MS/MS 测定血浆中丁丙诺啡的浓度。采用混合效应模型分析生理变量:在三个治疗组之间,各时间点的生理变量与基线相比没有变化,单匹马之间以及马匹之间的生理变量也没有变化(P > 0.3)。在对所有三个位置进行比较时,发现在尾基部腹侧使用丁丙诺啡时,可测量的血浆浓度大于 0.1 毫微克/毫升-1。在 TailTDP 组中,从 2 到 32 小时,平均血浆丁丙诺啡浓度都大于 0.1 纳克毫升-1。4 小时时,该组的平均浓度最高,为 0.25 纳克毫升/升:结论:与尾基部腹侧相比,掌骨和胫骨区域的丁丙诺啡吸收和血浆浓度更不稳定和不一致。必须针对最佳剂量、可达到的镇痛持续时间、可测量的血浆浓度变化以及行为和全身效应开展进一步研究。
{"title":"Plasma concentrations of buprenorphine administered via matrix-type transdermal patches applied at three different anatomical locations in healthy adult horses.","authors":"Vaidehi V Paranjape, Heather K Knych, Londa J Berghaus, Shyla Giancola, Jessica Cathcart, Rachel A Reed","doi":"10.3389/fpain.2024.1390322","DOIUrl":"10.3389/fpain.2024.1390322","url":null,"abstract":"<p><strong>Background: </strong>Anatomical location-dependent differences in transdermal opioid penetration are well described in human patients. Although this has been investigated in horses with fentanyl, there is no literature available on location-dependent plasma buprenorphine concentrations when administered as a transdermal matrix-type patch.</p><p><strong>Objective: </strong>This study aims to compare the plasma concentrations achieved from the matrix-type transdermal buprenorphine patches placed at different anatomical sites (metacarpus, gaskin, and ventral tail base) in healthy adult horses.</p><p><strong>Study design: </strong>This is a randomized experimental study with a Latin square design.</p><p><strong>Methods: </strong>Six adult horses were given each of three treatments with a minimum 10-day washout period. For each treatment, two 20 μg h<sup>-1</sup> matrix-type buprenorphine patches were applied to the ventral aspect of the tail base (Tail<sub>TDP</sub>), metacarpus region (Metacarpus<sub>TDP</sub>), or gaskin region (Gaskin<sub>TDP</sub>). Whole blood samples (for determination of buprenorphine concentration) and physiological variables were collected before (0 h) and at 0.5, 2, 4, 6, 8, 10, 12, 16, 24, 32, 48, 56, 72, 96 and 120 h after patches were applied. The patches were removed 96 h following placement and were analyzed for residual buprenorphine content. Buprenorphine concentrations were measured in plasma by LC-MS/MS. A mixed-effects model was used to analyze the physiological variables.</p><p><strong>Results: </strong>Between the three treatment groups, there was no change in physiological variables across timepoints as compared to baseline and when compared to each other in a single horse and between horses (<i>p</i> > 0.3). When comparing all three locations, the buprenorphine uptake was observed to be more consistent with respect to measurable plasma concentrations >0.1 ng ml<sup>-1</sup> when applied to the ventral aspect of the tail base. In the Tail<sub>TDP</sub> group, the mean plasma buprenorphine concentrations were >0.1 ng ml<sup>-1</sup> from 2 to 32 h. The highest group mean was 0.25 ng ml<sup>-1</sup> noted at 4 h.</p><p><strong>Conclusions: </strong>The metacarpal and gaskin regions presented more erratic and inconsistent buprenorphine uptake and plasma concentrations as compared to the ventral aspect of the tail base. Further research must be directed at investigating the optimal dose, achievable duration of analgesia, change in measurable plasma concentrations, and behavioral and systemic effects.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1390322"},"PeriodicalIF":2.5,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11220193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Integrative naturopathic approach for the management of sequestered lumbar disc herniation with neurological impairments: a case series with two year follow up. 病例报告:采用综合自然疗法治疗伴有神经系统损伤的腰椎间盘突出症:一个为期两年的系列病例随访。
Q2 CLINICAL NEUROLOGY Pub Date : 2024-05-31 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1367683
Sunil Paudel, Chethana A M Paudel, Karishma Silwal

Lumbar Disc Herniation (LDH) is a common condition, and contemporary pain research emphasizes the importance of adopting a comprehensive biopsychosocial perspective in pain treatment for positive clinical outcomes. Integrated Naturopathy and Yoga (INY) is a non-invasive medical system that takes a holistic and patient-centric approach to healing diseases. However, there is limited evidence on the effectiveness of INY, particularly in managing Sequestered LDH. We present two cases of patients experiencing radicular low back pain, lower limb weakness, and neuro-claudication who opted for conservative naturopathic management with INY. Following the INY treatments, both patients reported gradual relief from lower back pain, radicular pain, and neurological deficits. These findings are significant and contribute valuable evidence, suggesting that INY could be a viable therapeutic approach for managing sequestered LDH. This represents the first report on a non-invasive method for resolving sequestered LDH by utilizing INY.

腰椎间盘突出症(LDH)是一种常见疾病,当代疼痛研究强调,在疼痛治疗中采用全面的生物-心理-社会视角对于取得积极的临床疗效非常重要。综合自然疗法和瑜伽(INY)是一种非侵入性的医疗体系,它采用以患者为中心的整体方法来治疗疾病。然而,目前有关 INY 疗效的证据有限,尤其是在治疗闭塞性低密度脂蛋白血症方面。我们介绍了两例患者的病例,他们患有根性腰背痛、下肢无力和神经性跛行,并选择了使用INY进行保守的自然疗法。在接受 INY 治疗后,两名患者的下背痛、根性疼痛和神经功能缺损症状均逐渐缓解。这些研究结果意义重大,提供了宝贵的证据,表明 INY 可以作为一种可行的治疗方法来控制淤积的 LDH。这是利用 INY 解决 LDH 闭塞的非侵入性方法的首次报告。
{"title":"Case Report: Integrative naturopathic approach for the management of sequestered lumbar disc herniation with neurological impairments: a case series with two year follow up.","authors":"Sunil Paudel, Chethana A M Paudel, Karishma Silwal","doi":"10.3389/fpain.2024.1367683","DOIUrl":"10.3389/fpain.2024.1367683","url":null,"abstract":"<p><p>Lumbar Disc Herniation (LDH) is a common condition, and contemporary pain research emphasizes the importance of adopting a comprehensive biopsychosocial perspective in pain treatment for positive clinical outcomes. Integrated Naturopathy and Yoga (INY) is a non-invasive medical system that takes a holistic and patient-centric approach to healing diseases. However, there is limited evidence on the effectiveness of INY, particularly in managing Sequestered LDH. We present two cases of patients experiencing radicular low back pain, lower limb weakness, and neuro-claudication who opted for conservative naturopathic management with INY. Following the INY treatments, both patients reported gradual relief from lower back pain, radicular pain, and neurological deficits. These findings are significant and contribute valuable evidence, suggesting that INY could be a viable therapeutic approach for managing sequestered LDH. This represents the first report on a non-invasive method for resolving sequestered LDH by utilizing INY.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1367683"},"PeriodicalIF":0.0,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Non-biomedical perspectives on pain and its prevention and management. 社论:疼痛及其预防和管理的非生物学视角。
Q2 CLINICAL NEUROLOGY Pub Date : 2024-05-30 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1404074
Mark I Johnson, Antonio Bonacaro, Emmanouil Georgiadis, James Woodall
{"title":"Editorial: Non-biomedical perspectives on pain and its prevention and management.","authors":"Mark I Johnson, Antonio Bonacaro, Emmanouil Georgiadis, James Woodall","doi":"10.3389/fpain.2024.1404074","DOIUrl":"10.3389/fpain.2024.1404074","url":null,"abstract":"","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1404074"},"PeriodicalIF":0.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141319082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should cancer pain still be considered a separate category alongside acute pain and chronic non-cancer pain? Reflections on ICD-11. 癌症疼痛是否仍应被视为与急性疼痛和慢性非癌症疼痛并列的一个单独类别?对 ICD-11 的思考。
Q2 CLINICAL NEUROLOGY Pub Date : 2024-05-02 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1397413
Emmanuel Bäckryd

Introduction: Traditionally, cancer pain has often been viewed as an independent third major category in pain medicine alongside acute pain and chronic non-cancer pain. However, the new chronic pain category MG30 in the eleventh version of International Classification of Diseases (ICD-11) includes cancer-related pain as one of its seven subgroups. In light of this, the aim of the paper is to investigate whether the traditional trichotomy should be replaced by a dichotomy between acute pain and chronic pain, cancer-related pain being part of both groups depending on the duration of pain.

Methods: The rationale for viewing cancer pain as a separate category is reviewed.

Results: Cancer being a deadly disease, cancer pain has a life-and-death and existential dimension that is different from non-cancer pain. It seems sensible to believe that this is an additional dimension to the suffering caused by cancer pain, and that clinicians should therefore take this existential dimension into consideration when assessing pain.

Conclusion: Without challenging the place of chronic cancer-related pain under the MG30 heading, it is concluded that while using ICD-11 in the future, pain clinicians should continue being mindful of the fact that the reality of death shapes the experience of cancer pain. The traditional trichotomy is therefore still valid and mirrors the fact that human beings are vulnerable (acute pain), temporal (chronic pain) and mortal (cancer pain).

导言:传统上,癌症疼痛通常被视为疼痛医学中与急性疼痛和慢性非癌症疼痛并列的独立的第三大类。然而,在第十一版《国际疾病分类》(ICD-11)中,新的慢性疼痛类别 MG30 将癌症相关疼痛列为其七个亚组之一。有鉴于此,本文旨在探讨是否应将传统的三分法改为急性疼痛和慢性疼痛二分法,根据疼痛持续时间的长短,将癌症相关疼痛分为急性疼痛和慢性疼痛两组:方法:回顾了将癌症疼痛视为一个独立类别的理由:癌症是一种致命疾病,因此癌症疼痛具有不同于非癌症疼痛的生死和生存维度。因此,临床医生在评估疼痛时应考虑到这一存在维度:结论:在不质疑与癌症相关的慢性疼痛在 MG30 标题下的地位的前提下,得出的结论是,在未来使用 ICD-11 时,疼痛临床医生应继续注意死亡的现实会影响癌症疼痛的体验这一事实。因此,传统的三分法仍然有效,它反映了人类是脆弱的(急性疼痛)、暂时的(慢性疼痛)和致命的(癌症疼痛)这一事实。
{"title":"Should cancer pain still be considered a separate category alongside acute pain and chronic non-cancer pain? Reflections on ICD-11.","authors":"Emmanuel Bäckryd","doi":"10.3389/fpain.2024.1397413","DOIUrl":"https://doi.org/10.3389/fpain.2024.1397413","url":null,"abstract":"<p><strong>Introduction: </strong>Traditionally, cancer pain has often been viewed as an independent third major category in pain medicine alongside acute pain and chronic non-cancer pain. However, the new chronic pain category MG30 in the eleventh version of International Classification of Diseases (ICD-11) includes cancer-related pain as one of its seven subgroups. In light of this, the aim of the paper is to investigate whether the traditional trichotomy should be replaced by a dichotomy between acute pain and chronic pain, cancer-related pain being part of both groups depending on the duration of pain.</p><p><strong>Methods: </strong>The rationale for viewing cancer pain as a separate category is reviewed.</p><p><strong>Results: </strong>Cancer being a deadly disease, cancer pain has a life-and-death and existential dimension that is different from non-cancer pain. It seems sensible to believe that this is an additional dimension to the suffering caused by cancer pain, and that clinicians should therefore take this existential dimension into consideration when assessing pain.</p><p><strong>Conclusion: </strong>Without challenging the place of chronic cancer-related pain under the MG30 heading, it is concluded that while using ICD-11 in the future, pain clinicians should continue being mindful of the fact that the reality of death shapes the experience of cancer pain. The traditional trichotomy is therefore still valid and mirrors the fact that human beings are <i>vulnerable</i> (acute pain), <i>temporal</i> (chronic pain) and <i>mortal</i> (cancer pain).</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1397413"},"PeriodicalIF":0.0,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11096455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140960436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of physical activity education on shoulder girdle pain and muscle strength in participants with fibromyalgia: a pilot experimental study. 体育锻炼教育对纤维肌痛患者肩部疼痛和肌肉力量的影响:一项试点实验研究。
Q2 CLINICAL NEUROLOGY Pub Date : 2024-05-01 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1328796
Bastien Couëpel, Catherine Daneau, Mathieu Tremblay, Thomas Javelot, Jacques Abboud, Isabelle Pagé, Martin Descarreaux

Background: In patients with fibromyalgia, exercise and education are recommended to decrease pain level and improve pain management. The latest scientific evidence recommends to focus interventions on the upper limb. The aim of this pilot study was to compare the immediate effect of physical activity education vs. a control group on pain and muscle capacity in fibromyalgia patients.

Method: Fifty-six participants with fibromyalgia were randomized into an experimental group and a control group. The intervention consisted in watching a five-minute video that provided information about fibromyalgia, pain, kinesiophobia and physical activity. The control group watched a neutral five-minute video about beavers in Quebec. Following the video, participants performed a muscular fatigue task consisting of a repeated unilateral shoulder abduction task. At baseline and following the muscular fatigue task, maximal voluntary contraction (MVC) in shoulder abduction was assessed as well as pain level and pressure pain threshold (PPT) in the upper limb. Electromyographic activity was also assessed for upper trapezius and middle deltoid muscles. Two-way repeated measures analysis of variance was used to compare the MVC, PPT, and pain level before and after the muscular fatigue task between groups.

Results: The experimental group showed a significantly lower increase in pain than the control group in the middle deltoid muscle (p = 0.002) when assessed by verbal pain rating scale. No significant interaction or main effect of Group and Time were observed for the pain level at the upper trapezius and elbow extensor muscles nor for any of the PPT measures. According to electromyographic data, the median frequency values indicate that neither group experienced muscle fatigue during the repeated contraction task.

Conclusions: The preliminary results suggest that a short physical activity education video positively influenced middle deltoid pain following repeated abduction in participants with fibromyalgia. Electromyographic analysis showed no evidence of objective muscle fatigue, suggesting that there might be a partial disconnection between the perception of muscle fatigue and the physiological biomarkers associated with muscle fatigue.

背景:对于纤维肌痛患者,建议通过锻炼和教育来降低疼痛程度并改善疼痛控制。最新的科学证据建议将干预重点放在上肢。本试验性研究旨在比较体育锻炼教育与对照组对纤维肌痛患者疼痛和肌肉能力的直接影响:方法:56 名纤维肌痛患者被随机分为实验组和对照组。干预措施包括观看一段 5 分钟的视频,视频中提供了有关纤维肌痛、疼痛、运动恐惧症和体育锻炼的信息。对照组则观看五分钟关于魁北克海狸的中性视频。视频结束后,参与者进行了一项肌肉疲劳任务,包括重复单侧肩关节外展任务。在基线和肌肉疲劳任务之后,对肩部外展的最大自主收缩(MVC)以及上肢的疼痛程度和压痛阈值(PPT)进行了评估。此外,还对斜方肌上部和三角肌中部的肌电图活动进行了评估。采用双向重复测量方差分析来比较各组在肌肉疲劳任务前后的 MVC、PPT 和疼痛水平:结果:通过口头疼痛评分量表评估,实验组三角肌中部疼痛的增加明显低于对照组(P = 0.002)。在斜方肌上部和肘伸肌的疼痛程度上,以及在任何 PPT 测量中,均未观察到明显的组间交互作用或主效应。肌电图数据显示,频率中值表明两组在重复收缩任务中均未出现肌肉疲劳:初步结果表明,体育活动教育短片对纤维肌痛患者在重复外展后的三角肌中部疼痛有积极影响。肌电图分析未显示客观的肌肉疲劳证据,这表明肌肉疲劳的感知与肌肉疲劳相关的生理生物标志物之间可能存在部分脱节。
{"title":"Effect of physical activity education on shoulder girdle pain and muscle strength in participants with fibromyalgia: a pilot experimental study.","authors":"Bastien Couëpel, Catherine Daneau, Mathieu Tremblay, Thomas Javelot, Jacques Abboud, Isabelle Pagé, Martin Descarreaux","doi":"10.3389/fpain.2024.1328796","DOIUrl":"10.3389/fpain.2024.1328796","url":null,"abstract":"<p><strong>Background: </strong>In patients with fibromyalgia, exercise and education are recommended to decrease pain level and improve pain management. The latest scientific evidence recommends to focus interventions on the upper limb. The aim of this pilot study was to compare the immediate effect of physical activity education vs. a control group on pain and muscle capacity in fibromyalgia patients.</p><p><strong>Method: </strong>Fifty-six participants with fibromyalgia were randomized into an experimental group and a control group. The intervention consisted in watching a five-minute video that provided information about fibromyalgia, pain, kinesiophobia and physical activity. The control group watched a neutral five-minute video about beavers in Quebec. Following the video, participants performed a muscular fatigue task consisting of a repeated unilateral shoulder abduction task. At baseline and following the muscular fatigue task, maximal voluntary contraction (MVC) in shoulder abduction was assessed as well as pain level and pressure pain threshold (PPT) in the upper limb. Electromyographic activity was also assessed for upper trapezius and middle deltoid muscles. Two-way repeated measures analysis of variance was used to compare the MVC, PPT, and pain level before and after the muscular fatigue task between groups.</p><p><strong>Results: </strong>The experimental group showed a significantly lower increase in pain than the control group in the middle deltoid muscle (<i>p</i> = 0.002) when assessed by verbal pain rating scale. No significant interaction or main effect of Group and Time were observed for the pain level at the upper trapezius and elbow extensor muscles nor for any of the PPT measures. According to electromyographic data, the median frequency values indicate that neither group experienced muscle fatigue during the repeated contraction task.</p><p><strong>Conclusions: </strong>The preliminary results suggest that a short physical activity education video positively influenced middle deltoid pain following repeated abduction in participants with fibromyalgia. Electromyographic analysis showed no evidence of objective muscle fatigue, suggesting that there might be a partial disconnection between the perception of muscle fatigue and the physiological biomarkers associated with muscle fatigue.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1328796"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11094234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140946603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcutaneous electrical nerve stimulation vs. H-Wave® device stimulation-similar or different? 经皮神经电刺激与 H-Wave® 设备刺激--相似还是不同?
Q2 CLINICAL NEUROLOGY Pub Date : 2024-03-19 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1321148
Ashim Gupta, Stephen M Norwood
{"title":"Transcutaneous electrical nerve stimulation vs. H-Wave® device stimulation-similar or different?","authors":"Ashim Gupta, Stephen M Norwood","doi":"10.3389/fpain.2024.1321148","DOIUrl":"https://doi.org/10.3389/fpain.2024.1321148","url":null,"abstract":"","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1321148"},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985325/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of perioperative clinical hypnosis on heart rate variability in patients undergoing oncologic surgery: secondary outcomes of a randomized controlled trial. 围手术期临床催眠对肿瘤手术患者心率变异性的影响:随机对照试验的次要结果。
Q2 CLINICAL NEUROLOGY Pub Date : 2024-03-08 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1354015
Muhammad Abid Azam, Aliza Z Weinrib, P Maxwell Slepian, Brittany N Rosenbloom, Anna Waisman, Hance Clarke, Joel Katz

Introduction: Clinical hypnosis has been proposed for post-surgical pain management for its potential vagal-mediated anti-inflammatory properties. Evidence is needed to understand its effectiveness for post-surgical recovery. Iin this secondary outcome study, it was hypothesized that surgical oncology patients randomized to receive perioperative clinical hypnosis (CH) would demonstrate greater heart-rate variability (HRV) during rest and relaxation at a 1-month post-surgery assessment compared to a treatment-as-usual group (TAU).

Methods: After REB approval, trial registration and informed consent, 92 participants were randomized to receive CH (n = 45) or TAU (n = 47). CH participants received a CH session before surgery and during post-surgical in-hospital stay HRV was assessed during rest (5 min) and relaxation (10 min) before and 1-month after surgery. Pain intensity was obtained using a 0-10 numeric rating scale pre and post 1-week and 1-month post surgery.

Results: One month after surgery, HRV was significantly higher in CH group (n = 29) during rest and relaxation (both p < 0.05, d = 0.73) than TAU group (n = 28). By contrast, rest and relaxation HRV decreased from pre- to 1-month post-surgery for the TAU (both p < 0.001, d > 0.48) but not the CH group. Pain intensity increased from pre-surgery to 1-week post-surgery (p < 0.001, d = 0.50), and decreased from 1-week to 1-month post-surgery (p = 0.005, d = 0.21) for all participants.

Discussion: The results suggest that hypnosis prevents the deleterious effects of surgery on HRV by preserving pre-operative vagal activity. These findings underscore the potential of clinical hypnosis in mitigating the adverse effects of surgery on autonomic function and may have significant implications for enhancing post-surgical recovery and pain management strategies.

Clinical trial registration: ClinicalTrials.gov, identifier (NCT03730350).

导言:临床催眠因其潜在的迷走神经介导的抗炎特性而被提议用于手术后疼痛治疗。要了解催眠对手术后恢复的有效性,还需要证据。在这项次要结果研究中,我们假设随机接受围手术期临床催眠(CH)的肿瘤外科患者在手术后 1 个月的评估中,与正常治疗组(TAU)相比,在休息和放松时会表现出更大的心率变异性(HRV):在获得 REB 批准、试验注册和知情同意后,92 名参与者被随机分配到 CH 组(45 人)或 TAU 组(47 人)。CH组参与者在手术前接受一次CH治疗,并在手术后住院期间评估手术前和手术后1个月休息(5分钟)和放松(10分钟)时的心率变异。术前、术后 1 周和 1 个月的疼痛强度采用 0-10 数字评分量表进行评估:术后一个月,CH 组(29 人)在休息和放松时的心率变异(p d = 0.73)明显高于 TAU 组(28 人)。相比之下,从手术前到术后一个月,TAU 组的静息和放松心率变异均有所下降(p d 均 > 0.48),而 CH 组没有下降。所有参与者的疼痛强度从手术前增加到手术后一周(p d = 0.50),从手术后一周减少到手术后一个月(p = 0.005,d = 0.21):讨论:研究结果表明,催眠可通过保留术前迷走神经活动来防止手术对心率变异的有害影响。这些发现强调了临床催眠在减轻手术对自主神经功能的不良影响方面的潜力,并可能对加强术后恢复和疼痛管理策略具有重要意义:临床试验注册:ClinicalTrials.gov,标识符(NCT03730350)。
{"title":"Effects of perioperative clinical hypnosis on heart rate variability in patients undergoing oncologic surgery: secondary outcomes of a randomized controlled trial.","authors":"Muhammad Abid Azam, Aliza Z Weinrib, P Maxwell Slepian, Brittany N Rosenbloom, Anna Waisman, Hance Clarke, Joel Katz","doi":"10.3389/fpain.2024.1354015","DOIUrl":"10.3389/fpain.2024.1354015","url":null,"abstract":"<p><strong>Introduction: </strong>Clinical hypnosis has been proposed for post-surgical pain management for its potential vagal-mediated anti-inflammatory properties. Evidence is needed to understand its effectiveness for post-surgical recovery. Iin this secondary outcome study, it was hypothesized that surgical oncology patients randomized to receive perioperative clinical hypnosis (CH) would demonstrate greater heart-rate variability (HRV) during rest and relaxation at a 1-month post-surgery assessment compared to a treatment-as-usual group (TAU).</p><p><strong>Methods: </strong>After REB approval, trial registration and informed consent, 92 participants were randomized to receive CH (<i>n</i> = 45) or TAU (<i>n</i> = 47). CH participants received a CH session before surgery and during post-surgical in-hospital stay HRV was assessed during rest (5 min) and relaxation (10 min) before and 1-month after surgery. Pain intensity was obtained using a 0-10 numeric rating scale pre and post 1-week and 1-month post surgery.</p><p><strong>Results: </strong>One month after surgery, HRV was significantly higher in CH group (<i>n</i> = 29) during rest and relaxation (both <i>p</i> < 0.05, <i>d</i> = 0.73) than TAU group (<i>n</i> = 28). By contrast, rest and relaxation HRV decreased from pre- to 1-month post-surgery for the TAU (both <i>p</i> < 0.001, <i>d</i> > 0.48) but not the CH group. Pain intensity increased from pre-surgery to 1-week post-surgery (<i>p</i> < 0.001, <i>d</i> = 0.50), and decreased from 1-week to 1-month post-surgery (<i>p</i> = 0.005, <i>d</i> = 0.21) for all participants.</p><p><strong>Discussion: </strong>The results suggest that hypnosis prevents the deleterious effects of surgery on HRV by preserving pre-operative vagal activity. These findings underscore the potential of clinical hypnosis in mitigating the adverse effects of surgery on autonomic function and may have significant implications for enhancing post-surgical recovery and pain management strategies.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov, identifier (NCT03730350).</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1354015"},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10957530/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140208381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture for pain and pain-related disability in deep infiltrating endometriosis. 针灸治疗深部浸润性子宫内膜异位症的疼痛和与疼痛相关的残疾。
Q2 CLINICAL NEUROLOGY Pub Date : 2024-03-08 eCollection Date: 2024-01-01 DOI: 10.3389/fpain.2024.1279312
Giulia Chiarle, Gianni Allais, Silvia Sinigaglia, Gisella Airola, Sara Rolando, Fabiola Bergandi, Salvatore Micalef, Chiara Benedetto

Objectives: To evaluate the efficacy of acupuncture in relieving symptoms (dysmenorrhea, dyspareunia, pelvic pain and dyschezia) intensity, improving functional disability, reducing the number of days per months of dysmenorrhea, the frequency and the efficacy of analgesic use in deep infiltrating endometriosis (DIE). The safety profile was also evaluated.

Methods: The study sample was 34 patients with DIE; for 2 months (T-2, T-1) the women recorded diary notes on the numbers of days of menstruation, the presence, intensity, and disability related to dysmenorrhea, dyspareunia, pelvic pain, and dyschezia. They then received a total of 15 acupuncture treatments over 6 months (T1-T6; once a week for 12 weeks, then once a month for 3 months).

Results: Dysmenorrhea intensity was decreased during treatment. A decrease of at least 50% in number of days of dysmenorrhea, and a decrease in moderate-to-severe disability starting from T1 to T6 was recorded for 58.6% of patients. Dyspareunia intensity steadily decreased starting at T2; the percentage of women with moderate-to-severe disability declined from 73.3% at T-2, to 36.9% at T3, T4, and T5. A decrease in pelvic pain score was noted starting at T1; the percentage of disability decreased from 83.3% at T-2 to 33.3% at T3 and T6. The intensity of dyschezia decreased from T-2 to T3 and T4 and then increased slightly. Analgesic drug use was lower during treatment and its efficacy appeared to be greater.

Conclusions: The limitations notwithstanding our study-findings show that acupuncture was safe and effective in reducing pain intensity and symptoms-related disability. Larger-scale studies are needed to compare acupuncture and pharmacotherapy for endometriosis-related pain.

研究目的评估针灸在缓解深部浸润性子宫内膜异位症(DIE)患者症状(痛经、排便困难、盆腔疼痛和月经失调)强度、改善功能障碍、减少痛经月天数、镇痛剂使用频率和疗效方面的疗效。此外,还对其安全性进行了评估:研究样本为 34 名 DIE 患者;在两个月的时间里(T-2、T-1),妇女们记录了月经天数、痛经、排便困难、盆腔疼痛和月经失调的存在、强度和残疾情况。然后,她们在 6 个月内共接受了 15 次针灸治疗(T1-T6;每周一次,共 12 周,然后每月一次,共 3 个月):结果:治疗期间痛经的强度有所降低。从 T1 到 T6,58.6% 的患者痛经天数至少减少了 50%,中度至重度残疾程度有所减轻。痛经强度从 T2 开始稳步下降;中度至重度残疾妇女的比例从 T2 的 73.3%下降到 T3、T4 和 T5 的 36.9%。盆腔疼痛评分从 T1 开始下降;残疾比例从 T2 的 83.3% 下降到 T3 和 T6 的 33.3%。排便困难的程度从 T-2 到 T3 和 T4 有所减轻,然后略有加重。治疗期间镇痛药的用量较少,疗效似乎更好:尽管存在局限性,但我们的研究结果表明,针灸在减轻疼痛强度和症状相关残疾方面是安全有效的。需要进行更大规模的研究,以比较针灸和药物疗法对子宫内膜异位症相关疼痛的治疗效果。
{"title":"Acupuncture for pain and pain-related disability in deep infiltrating endometriosis.","authors":"Giulia Chiarle, Gianni Allais, Silvia Sinigaglia, Gisella Airola, Sara Rolando, Fabiola Bergandi, Salvatore Micalef, Chiara Benedetto","doi":"10.3389/fpain.2024.1279312","DOIUrl":"10.3389/fpain.2024.1279312","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the efficacy of acupuncture in relieving symptoms (dysmenorrhea, dyspareunia, pelvic pain and dyschezia) intensity, improving functional disability, reducing the number of days per months of dysmenorrhea, the frequency and the efficacy of analgesic use in deep infiltrating endometriosis (DIE). The safety profile was also evaluated.</p><p><strong>Methods: </strong>The study sample was 34 patients with DIE; for 2 months (T-2, T-1) the women recorded diary notes on the numbers of days of menstruation, the presence, intensity, and disability related to dysmenorrhea, dyspareunia, pelvic pain, and dyschezia. They then received a total of 15 acupuncture treatments over 6 months (T1-T6; once a week for 12 weeks, then once a month for 3 months).</p><p><strong>Results: </strong>Dysmenorrhea intensity was decreased during treatment. A decrease of at least 50% in number of days of dysmenorrhea, and a decrease in moderate-to-severe disability starting from T1 to T6 was recorded for 58.6% of patients. Dyspareunia intensity steadily decreased starting at T2; the percentage of women with moderate-to-severe disability declined from 73.3% at T-2, to 36.9% at T3, T4, and T5. A decrease in pelvic pain score was noted starting at T1; the percentage of disability decreased from 83.3% at T-2 to 33.3% at T3 and T6. The intensity of dyschezia decreased from T-2 to T3 and T4 and then increased slightly. Analgesic drug use was lower during treatment and its efficacy appeared to be greater.</p><p><strong>Conclusions: </strong>The limitations notwithstanding our study-findings show that acupuncture was safe and effective in reducing pain intensity and symptoms-related disability. Larger-scale studies are needed to compare acupuncture and pharmacotherapy for endometriosis-related pain.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"5 ","pages":"1279312"},"PeriodicalIF":0.0,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10957595/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140208379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in pain research (Lausanne, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1